Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

摘要: This report updates CDC's recommendations for using yellow fever (YF) vaccine (CDC. Yellow vaccine: of the Advisory Committee on Immunizations Practices: MMWR 2002;51[No. RR-17]). Since previous YF were published in 2002, new or additional information has become available epidemiology YF, safety profile vaccine, and health regulations related to vaccine. summarizes current describes immunogenicity data provides use among travelers laboratory workers. is a vectorborne disease resulting from transmission virus (YFV) human bite an infected mosquito. It endemic sub-Saharan Africa tropical South America estimated cause 200,000 cases clinical 30,000 deaths annually. Infection humans capable producing hemorrhagic fatal 20%-50% persons with severe disease. Because no treatment exists disease, prevention critical lower risk mortality. A traveler's acquiring YFV determined by multiple factors, including immunization status, location travel, season, duration exposure, occupational recreational activities while traveling, local rate at time travel. All countries which should be advised risks contracting methods prevent it, personal protective measures receipt Administration recommended aged >or=9 months who are traveling living areas transmission. serious adverse events can occur following administration, health-care providers vaccinate only exposure require proof vaccination country entry. To minimize events, observe contraindications, consider precautions before administering issue medical waiver if indicated.